Comparative Study of the Chemical Profile, Cytotoxic Activity, and Molecular Docking of Serenoa Repens Extract and a Pharmaceutical Product
October 2025
in “
Scientific Reports
”
The study compares the chemical profile, cytotoxic activity, and molecular docking of Serenoa repens extract (S1) and a pharmaceutical product containing Serenoa repens (S2). Using LCHR-ESI-MS, approximately 50 bioactive constituents, mainly polyphenols, were identified in both samples. The MTT cytotoxic study on Pc3 and DU-145 prostate cancer cell lines showed that both S1 and S2 have anti-inflammatory, pro-apoptotic, and anti-androgenic effects, with S1 showing higher activity against Pc3 and S2 against DU-145. Molecular docking and MD simulation studies identified Quercetin-3-(6''-malonyl)-Glucoside and Luteolin 7-(6''-malonylneohesperidoside) as having significant inhibitory potential against CDK2. These findings suggest Serenoa repens' potential as a natural treatment and guide the development of more effective pharmaceutical formulations.